Callan JMB Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CJMB research report →
Price Chart
About the company
Callan JMB Inc. , operating primarily through its subsidiary Coldchain Technology Services, LLC, specializes in providing temperature-controlled logistics solutions specifically for the life sciences sector. The company's services include comprehensive frozen shipping capabilities essential for a wide range of sensitive biological and medical materials.
- CEO
- Wayne Williams
- IPO
- 2025
- Employees
- 19
- HQ
- Spring Branch, TX, US
Get TickerSpark's AI analysis on CJMB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $11.37M
- P/E
- -1.19
- PEG
- 0.03
- P/S
- 2.23
- P/B
- 19.71
- EV/EBITDA
- -1.29
- Div Yield
- 0.00%
- Gross Margin
- 39.94%
- Op Margin
- -135.47%
- Net Margin
- -191.97%
- ROE
- -444.91%
- ROIC
- -202.00%
Latest fiscal year · YoY change
- Revenue
- $5.72M-12.8%
- Gross Profit
- $2.10M-17.9%
- Op Income
- $-6,492,491
- Net Income
- $-7,966,366-247.3%
- EPS
- $-1.82-109.2%
- OCF Growth
- -941.4%
- FCF Growth
- -1144.9%
- 52W High
- $5.61
- 52W Low
- $0.65
- 50D MA
- $1.31
- 200D MA
- $1.64
- Beta
- -0.71
- RSI (14)
- 62
- Avg Volume
- 2.21M
No earnings-call transcripts are available for CJMB yet.
- Free Float
- 31.6%
- Shares Outstanding
- 4.78M
- Float Shares
- 1.51M
of shares held by institutions
12 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Held by 4 ETFs
Biggest fund positions in CJMB by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 30, 25 | Dial Gerald | buy | 10,000 |
| Mar 20, 26 | Croyle David J | buy | 10,195 |
| Mar 6, 26 | Croyle David J | buy | 14,805 |
| Feb 4, 25 | Dial Gerald | other | 25,000 |
| Dec 30, 25 | Dial Gerald | buy | 1,539 |
| Dec 30, 25 | Dial Gerald | buy | 461 |
| Dec 16, 25 | Williams Wayne D | buy | 5,000 |
| Dec 12, 25 | Williams Wayne D | buy | 4,926 |
| Dec 11, 25 | Williams Wayne D | buy | 62 |
| Dec 15, 25 | Williams Wayne D | buy | 10,810 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CJMB coverage
Recent articles, reports, and earnings notes.
No research on CJMB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CJMB report →Callan JMB's Callan Power to Acquire Reger Oil Assets in The Williston Basin; Northern Oil and Gas Former CEO and Founder Michael Reger Named President of Callan Power and Board Member
globenewswire.com · Aug 20
Callan JMB Inc. Regains Compliance with Nasdaq's Minimum Bid Price Requirement
globenewswire.com · Aug 17
Callan JMB Continues Longstanding Emergency Preparedness Support for the City of Chicago During Lollapalooza Weekend
globenewswire.com · Aug 10
Callan JMB Expands Atlas Complex, Advances Recurring Infrastructure Services Business with Cavalry 1838 Equine Biosciences
globenewswire.com · Aug 4
Callan JMB and Alabama State University Break Ground on Atlas Complex, Launching an Unprecedented Strategic Partnership to Advance U.S. Pharmaceutical Manufacturing and Supply Chain Resilience
globenewswire.com · Jul 29
Callan JMB and Alabama State University Announce Strategic Partnership to Advance U.S. Pharmaceutical Manufacturing and Supply Chain Resilience
globenewswire.com · Jul 16
Callan JMB and Alabama State University Announce Strategic Partnership to Advance U.S. Pharmaceutical Manufacturing and Supply Chain Resilience
globenewswire.com · Jul 16
Callan JMB Inc. and Alabama State University Partner to Advance Workforce Development, Research, and Pharmaceutical Innovation at the Atlas Complex
globenewswire.com · Jul 8
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.